{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T05:08:53Z","timestamp":1721452133382},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T00:00:00Z","timestamp":1279152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s10620-010-1328-9","type":"journal-article","created":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T21:14:01Z","timestamp":1279142041000},"page":"845-852","source":"Crossref","is-referenced-by-count":6,"title":["Antiglycan Antibodies in Greek Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"56","author":[{"given":"Ioannis E.","family":"Koutroubakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Drygiannakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Tsirogianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantelis","family":"Oustamanolakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Karmiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Papamichael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerassimos J.","family":"Mantzaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias A.","family":"Kouroumalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,15]]},"reference":[{"key":"1328_CR1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","volume":"42","author":"JF Quinton","year":"1998","unstructured":"Quinton JF, Sendid B, Reumaux D, et al. Anti- Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788\u2013791.","journal-title":"Gut"},{"key":"1328_CR2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1572-0241.2001.03613.x","volume":"96","author":"M Peeters","year":"2001","unstructured":"Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730\u2013734.","journal-title":"Am J Gastroenterol"},{"key":"1328_CR3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00054725-200108000-00003","volume":"7","author":"WJ Sandborn","year":"2001","unstructured":"Sandborn WJ, Loftus EV Jr, Colombel JF, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn\u2019s disease. Inflamm Bowel Dis. 2001;7:192\u2013201.","journal-title":"Inflamm Bowel Dis"},{"key":"1328_CR4","first-page":"449","volume":"96","author":"IE Koutroubakis","year":"2001","unstructured":"Koutroubakis IE, Petinaki E, Mouzas IA, et al. Anti Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:449\u2013454.","journal-title":"Am J Gastroenterol"},{"key":"1328_CR5","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1572-0241.2004.40369.x","volume":"99","author":"A Zholudev","year":"2004","unstructured":"Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn\u2019s disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004;99:2235\u20132241.","journal-title":"Am J Gastroenterol"},{"key":"1328_CR6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","volume":"126","author":"WS Mow","year":"2004","unstructured":"Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn\u2019s disease. Gastroenterology. 2004;126:414\u2013424.","journal-title":"Gastroenterology"},{"key":"1328_CR7","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","volume":"128","author":"SR Targan","year":"2005","unstructured":"Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn\u2019s disease. Gastroenterology. 2005;128:2020\u20132028.","journal-title":"Gastroenterology"},{"key":"1328_CR8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1572-0241.2006.00456.x","volume":"101","author":"MC Dubinsky","year":"2006","unstructured":"Dubinsky MC, Lin YC, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn\u2019s disease: immune responses predict disease progression. Am J Gastroenterol. 2006;101:360\u2013367.","journal-title":"Am J Gastroenterol"},{"key":"1328_CR9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/j.gastro.2006.04.030","volume":"131","author":"I Dotan","year":"2006","unstructured":"Dotan I, Fishman S, Dgani Y, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn\u2019s disease. Gastroenterology. 2006;131:366\u2013378.","journal-title":"Gastroenterology"},{"key":"1328_CR10","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.3748\/wjg.14.5115","volume":"14","author":"X Li","year":"2008","unstructured":"Li X, Conklin L, Alex P. New serological biomarkers of inflammatory bowel disease. World J Gastroenterol. 2008;14:5115\u20135124.","journal-title":"World J Gastroenterol"},{"key":"1328_CR11","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2006.108043","volume":"56","author":"M Ferrante","year":"2007","unstructured":"Ferrante M, Henckaerts L, Joossens M, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 2007;56:1394\u20131403.","journal-title":"Gut"},{"key":"1328_CR12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1572-0241.2007.01652.x","volume":"103","author":"M Papp","year":"2008","unstructured":"Papp M, Altorjay I, Dotan N, et al. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2\/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol. 2008;103:665\u2013681.","journal-title":"Am J Gastroenterol"},{"key":"1328_CR13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ibd.20368","volume":"14","author":"D Simondi","year":"2008","unstructured":"Simondi D, Mengozzi G, Betteto S, et al. Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:645\u2013651.","journal-title":"Inflamm Bowel Dis"},{"key":"1328_CR14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ibd.21046","volume":"16","author":"F Rieder","year":"2010","unstructured":"Rieder F, Schleder S, Wolf A, et al. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn\u2019s disease behavior. Inflamm Bowel Dis. 2010;16:263\u2013274.","journal-title":"Inflamm Bowel Dis"},{"key":"1328_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.2005.081950a","volume":"55","author":"EF Stange","year":"2006","unstructured":"Stange EF, Travis SPL, Vermeire S, et al. European Crohn\u2019s and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis. Gut. 2006;55:1\u201315.","journal-title":"Gut"},{"issue":"Suppl A","key":"1328_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5\u201336.","journal-title":"Can J Gastroenterol"},{"key":"1328_CR17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study. Gastroenterology. 1976;70:439\u2013444.","journal-title":"Gastroenterology"},{"key":"1328_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","volume":"43","author":"RS Walmsley","year":"1998","unstructured":"Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29\u201332.","journal-title":"Gut"},{"key":"1328_CR19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1191\/0961203306lu2331oa","volume":"15","author":"N Dotan","year":"2006","unstructured":"Dotan N, Altstock RT, Schwarz M, Dukler A. Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus. 2006;15:442\u2013450.","journal-title":"Lupus"},{"key":"1328_CR20","doi-asserted-by":"crossref","unstructured":"Rieder F, Schleder S, Wolf A, et al. Serum anti-glycan antibodies predict complicated Crohn\u2019s disease behavior: A cohort study. Inflamm Bowel Dis. 2010 [Epub ahead of print] PMID: 20024902.","DOI":"10.1002\/ibd.21179"},{"key":"1328_CR21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ibd.20985","volume":"16","author":"M Joossens","year":"2010","unstructured":"Joossens M, Van Steen K, Branche J, et al. Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn\u2019s disease. Inflamm Bowel Dis. 2010;16:58\u201367.","journal-title":"Inflamm Bowel Dis"},{"key":"1328_CR22","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","volume":"122","author":"S Joossens","year":"2002","unstructured":"Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002;122:1242\u20131247.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1328-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1328-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1328-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T02:13:50Z","timestamp":1559268830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1328-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1328"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1328-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,15]]}}}